Last C$7.17 CAD
Change Today +0.04 / 0.56%
Volume 5.8K
RX On Other Exchanges
Symbol
Exchange
OTC US
Venture
As of 3:43 PM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

RX

Industry Average

Ratio data TTM as of 03/31/2014

Profitability - biosyent inc (RX)

Return on Assets

Industry Comparison
31.51%

Return on Equity

Industry Comparison
48.29%

Return on Capital

Industry Comparison
37.70%

Margin Analysis - biosyent inc (RX)

Gross Margin

Industry Comparison
78.46%

Levered Free Cash Flow Margin

Industry Comparison
13.75%

EBITDA Margin

Industry Comparison
30.34%

SG&A Margin

Industry Comparison
47.58%

Asset Turnover - biosyent inc (RX)

Total Assets Turnover

Industry Comparison
1.7x

Accounts Receivables Turnover

Industry Comparison
7.0x

Fixed Assets Turnover

Industry Comparison
114.2x

Inventory Turnover

Industry Comparison
4.0x

Credit Ratios - biosyent inc (RX)

Current Ratio

Industry Comparison
6.2x

Quick Ratio

Industry Comparison
5.4x

Long-Term Solvency - biosyent inc (RX)

Total Debt/Equity

Industry Comparison
--
No data available

Total Liabilities/Total Assets

Industry Comparison
15.15%

Growth Over Prior Year - biosyent inc (RX)

Total Revenue

Industry Comparison
53.77%

Tangible Book Value

Industry Comparison
65.87%

EBITDA

Industry Comparison
64.01%

Gross Profit

Industry Comparison
51.74%

Receivables

Industry Comparison
30.20%

Inventory

Industry Comparison
89.28%

Diluted EPS Before Extra

Industry Comparison
36.42%

Capital Expenditures

Industry Comparison
171.89%

Cash From Ops.

Industry Comparison
74.62%

Levered Free Cash Flow

Industry Comparison
104.93%
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RX:CN C$7.17 CAD +0.04

RX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RX.
View Industry Companies
 

Industry Analysis

RX

Industry Average

Valuation RX Industry Range
Price/Earnings 50.9x
Price/Sales 11.6x
Price/Book 18.7x
Price/Cash Flow 48.7x
TEV/Sales 11.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOSYENT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.